Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haferlach

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|July 9, 2011
Eμ/miR-125b transgenic mice develop lethal B-cell malignanciesY Enomoto, J Kitaura, K Hatakeyama, et al.
Leukemia|September 29, 2012
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcomeS Schnittger, C Eder, S Jeromin, et al.
Leukemia|October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosisM Jawhar, J Schwaab, S Schnittger, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromesT Haferlach, Y Nagata, V Grossmann, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)B Hanfstein, M C Müller, R Hehlmann, et al.
Leukemia|February 10, 2016
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemiaU Krug, W E Berdel, R P Gale, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|July 9, 2011
Eμ/miR-125b transgenic mice develop lethal B-cell malignanciesY Enomoto, J Kitaura, K Hatakeyama, et al.
Leukemia|September 29, 2012
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcomeS Schnittger, C Eder, S Jeromin, et al.
Leukemia|October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosisM Jawhar, J Schwaab, S Schnittger, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromesT Haferlach, Y Nagata, V Grossmann, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)B Hanfstein, M C Müller, R Hehlmann, et al.
Leukemia|February 10, 2016
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemiaU Krug, W E Berdel, R P Gale, et al.
Pageof 5